ArticleMedicine2026
Clinicopathological characteristics and prognosis of brain metastasis in non-small cell lung cancer: A retrospective study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to investigate the clinicopathological features and prognosis of brain metastasis in non-small cell lung cancer (NSCLC). A total of 80 patients with brain metastases from NSCLC admitted to our hospital from Jan 2021 to Dec 2023 were retrospectively selected as patients in the brain metastasis group. One hundred patients with NSCLC who were admitted during the same period were selected as patients with non-brain metastasis. The relationship between different clinicopathological characteristics of lung cancer and brain metastasis was analyzed, the survival curves of patients in the 2 groups were compared, and the prognostic impact was analyzed by univariate and multifactor Logistics regression. The differences were statistically significant among histological types, metastasis time, and gene mutations (P < .05). The results of single and multivariate Logistics regression analysis showed that age, smoking history, T-stage, and tumor node metastasis stage were independent factors influencing the prognostic outcome of patients with brain metastasis of NSCLC (P < .05). Age, smoking history, T-stage, and tumor node metastasis stage are independent influencing factors on the prognosis of patients with brain metastases from NSCLC, and intervention should be taken based on the influencing factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.